7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazole

Catalog No. :
ACDBMH850
CAS No. :
2137501-14-3
Molecular Formula :
C13H16BNO3
Molecular Weight :
245.09

IUPAC Name:7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazole

7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$83.00Login to see priceIn stockInquiry
5g95%$287.00Login to see priceIn stockInquiry
25g95%$1435.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazole
IUPAC Name7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazole
MDL No.MFCD16995817
Molecular FormulaC13H16BNO3
Molecular Weight245.09
SMILESCC1(C)OB(C2=C(OC=N3)C3=CC=C2)OC1(C)C
InChI KeyMJDSPMWXACIOLG-UHFFFAOYSA-N
Synonym7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazole;7-(tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3-benzoxazole
CAS No.2137501-14-3
PubChem CID72220853

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACDBMH850 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIQOE795 route compound structure diagram
    ACIQOE795885270-14-4 In Stock
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  4. Then
  5. ACDBMH850 route product structure diagram
    ACDBMH8502137501-14-3 In Stock
Inquiry

2. ACDBMH850 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDBMH850 route product structure diagram
    ACDBMH8502137501-14-3 In Stock
Inquiry

Comments (0)